Abstract

We discussed nuclear technologies to produce radioactive isotopes, with a focus on radionuclides used as radiopharmaceuticals in novel methods of cancer diagnosis and radionuclide therapy—theranostics. New target materials and nuclear reactions to produce these radionuclides were considered. The experimental and theoretical results of excitation functions of reactions (p, xn) studies in energy range 6–80 MeV for medium mass nuclear systems to produce radionuclides: scandium, technetium, antimony, terbium are presented. These radionuclides are promising for their use in nuclear medicine methods for diagnostics, therapy and theranostics.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.